Nippon Express USA, Inc. (Toshiya Abe, President; hereinafter, “NX USA”), a Group company of Nippon Express Holdings, Inc. (Mitsuru Saito, President), has obtained Good Distribution Practice (GDP) certification effective December 20, 2021 for forwarding operations, inclusive of temporary storage, at a temperature-controlled facility in its own CFS near John F. Kennedy International Airport (hereinafter, “JFK Airport”) in New York City, evidencing its compliance with GDP standards for the proper distribution of pharmaceuticals.
The US Northeast is home to a large number of companies involved in the pharmaceutical and medical device businesses, and demand in those sectors is expected to rise in future. NX USA’s New York Branch has its own warehouse near JFK Airport that is fully equipped with a temperature-controlled 24m2 facility dedicated to pharmaceutical products and capable of both refrigerated (2ºC-8ºC) and constant-temperature (15ºC-25ºC) storage, enabling the Branch to provide a safe and high-quality pharmaceutical distribution platform by operating regular shuttle trucking services that deliver cargo to other Nippon Express locations across the Northeast as early as the following morning.
The NX Group will continue stepping up its initiatives in the pharmaceutical industry, identified as a priority industry in the Group’s Business Plan, and globally enhancing and expanding its services to meet the increasingly sophisticated and diversified pharmaceutical transport needs of its customers.
